Keywords: strong, ph, iii, data, titan, opioid, addiction

Strong Ph III data for Titan's opioid addiction implant

Article | 04 August 2008

The USA's Titan Pharmaceuticals has reported positive, statistically-significant results from a Phase III trial of Probuphine, a subcutaneous implant designed ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

Buprenex

Buprenorphine

Go to drug listing